[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2017177701A1 - 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法 - Google Patents

一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法 Download PDF

Info

Publication number
WO2017177701A1
WO2017177701A1 PCT/CN2016/108785 CN2016108785W WO2017177701A1 WO 2017177701 A1 WO2017177701 A1 WO 2017177701A1 CN 2016108785 W CN2016108785 W CN 2016108785W WO 2017177701 A1 WO2017177701 A1 WO 2017177701A1
Authority
WO
WIPO (PCT)
Prior art keywords
closure plate
flexible
flexible closure
mitral
hook card
Prior art date
Application number
PCT/CN2016/108785
Other languages
English (en)
French (fr)
Inventor
贺照明
荆腾
张凯亮
Original Assignee
上海甲悦医疗器械有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海甲悦医疗器械有限公司 filed Critical 上海甲悦医疗器械有限公司
Priority to US16/086,508 priority Critical patent/US11007060B2/en
Priority to EP16898513.3A priority patent/EP3443937B1/en
Publication of WO2017177701A1 publication Critical patent/WO2017177701A1/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
    • A61F2/2487—Devices within the heart chamber, e.g. splints
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00579—Barbed implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592—Elastic or resilient implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00623—Introducing or retrieving devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0083—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using hook and loop-type fasteners

Definitions

  • the invention relates to the field of human heart repair technology and medical instruments, in particular to a device capable of repairing mitral regurgitation of the heart.
  • the human heart and valve are shown in Figure 1.
  • the left ventricle 3 is located at the upper left of the apex 4, the mitral valve 2 is located between the left atrium 1 and the left ventricle 3, and the mitral valve 2 controls the flow of blood from the left atrium 1 into the left ventricle 3 .
  • the dysfunctional mitral valve 2 causes the two leaflets of the mitral valve 2 to be incompletely closed, causing blood to flow back from the left ventricle 3 back to the left atrium during systole. Mitral regurgitation will cause pulmonary congestion and left ventricular 3 hypertrophy, which ultimately leads to heart failure and death in the patient.
  • the structure of the mitral valve 2 is shown in Figure 2.
  • the mitral valve 2 is a complex one-way valve structure that withstands blood pressure, consisting of a mitral annulus 2.1, a anterior leaflet 2.2, a posterior leaflet 2.3, a chordae 2.4, a nipple Myocardium 2.5 and myocardium on the left ventricular wall.
  • the papillary muscle 2.5 is attached to the left ventricular wall, and the anterior leaflet 2.2 and the posterior leaflet 2.3 are attached to the mitral annulus 2.1.
  • the mitral annulus 2.1 is an internal tissue structure that connects the anterior leaflet 2.2, the posterior leaflet 2.3, and the left ventricular wall.
  • the tissue structure of the mitral annulus 2.1 is divided into a fibrous layer of the anterior medial segment and a muscle layer of the posterolateral segment.
  • the chordae 2.4 starts from the papillary muscle 2.5 and attaches to the leaflets to prevent the anterior leaflet 2.2 and the posterior leaflet 2.3 from collapsing into the left atrium when the heart contracts.
  • Fig. 3 and Fig. 4 The state of the normal mitral valve closure is shown in Fig. 3 and Fig. 4. After the mitral valve is closed, there is no gap between the anterior leaflet 2.2 and the posterior leaflet 2.3, and the anterior and posterior leaflet junctions 5 are completely closed. There will be reflux.
  • Fig. 5 and Fig. 6 a gap exists between the anterior and posterior leaflet junctions 5 of the mitral valve 2, and the gap between the anterior and posterior leaflet junctions causes the blood to contract in the heart.
  • this reflux is called mitral regurgitation, which reduces heart efficiency and causes heart failure.
  • the object of the present invention is to solve the problems existing in the prior art mitral regurgitation treatment method, and provide a transapical mitral flexible closure plate occlusion for repairing mitral regurgitation, obstructing mitral regurgitation Channel, effectively preventing the two tips
  • the regurgitation of the lobes the invention also provides a method for implanting the mitral flexible closure plate occlusion body, which is implanted into the regurgitation position of the mitral valve before and after the mitral valve closure by minimally invasive surgery, without opening the chest, Happy, less trauma to the human body, no residual reflux occurs, and high reliability.
  • a mitral flexible occlusion plate occlusion body adopts a technical solution that the mitral flexible closure plate occlusion body comprises a flexible closure plate, a guide wire, a guide ring and a fixed plug fixedly implanted at the apex of the heart, the flexible closure plate being located at the anterior and posterior leaflet junction of the heart, each fixed in the left and right mitral annulus at the junction of the anterior and posterior leaflets
  • the left and right guide wires respectively pass through the hook cards on the same side and are fixedly connected to the same upper portion of the flexible closing plate, and the left lower portion and the lower right portion of the flexible closing plate are fixedly connected with a guiding ring, left The right two guiding wires respectively pass through the guiding ring on the same side and are fixedly connected to the fixing plug.
  • the longitudinal section of the flexible closure panel is an inverted isosceles trapezoidal structure, and the flexible closure panel can be crimped into an elongated cylinder along the upper bottom edge or the lower bottom edge.
  • a support rod is embedded in the edge of the bottom edge of the flexible closure panel along the length of the lower base, and the lower bottom edge of the flexible closure panel is fixedly connected to one end of the traction wire, and the other end of the traction wire is fixedly connected to the fixing plug.
  • the plurality of traction wires have a plurality of pulling wires, and one end of the plurality of pulling wires is evenly connected to the flexible closing plate along the length direction of the lower bottom edge of the flexible closing plate, and the other ends of the plurality of pulling wires are fixedly connected to the fixing plug.
  • the apical implanted mitral flexible closure plate obstruction method adopts a technical solution: a small incision is made in the left apex of the chest to pass through the apex, and a sacral operation is performed at the apical position, and the apical cannula is used. Inserting the left ventricle from the purse and tightening the pouch to fix the apical sleeve also includes the following steps:
  • the guide wire is placed on the hook card, and the hook card is placed in the hook card implantation catheter.
  • the hook card implants the catheter through the apical sleeve into the left ventricle to reach the joint of the front and rear leaflets, and the hook is pulled from the hook by the push rod.
  • the card is inserted into the catheter to insert the hook card into the mitral annulus; the two hooks are respectively implanted twice in the left and right mitral annulus at the junction of the anterior and posterior valvelets; After the hook card is implanted, the hook card is inserted into the catheter, and both ends of the two guiding wires passing through the hook card are led to the outside through the apical catheter;
  • the flexible closure plate and the guide ring are formed into a single piece in vitro, and one end of the two guiding wires of the external body is respectively fixedly connected with the upper side of the flexible closing plate and the other end respectively passes through the guiding ring of the same side;
  • the flexible closure plate is then crimped into a cylinder, and the entire piece of the cylinder is placed in a closed plate implantation catheter.
  • the closure plate is inserted into the catheter through the apical cannula into the left ventricle, and the flexible closure plate is pushed out to expand.
  • the guide wire of the guide ring is guided to the outside of the body through the closed plate implantation catheter, and finally the guide wire is tensioned so that the upper left portion and the upper right portion of the flexible closure plate are respectively located at the hook position on the same side;
  • step B the lower bottom edge of the flexible closure plate is fixedly connected to one end of the traction wire in vitro, and
  • the support rod is fixedly embedded in the lower bottom edge of the flexible closure panel, and the flexible closure panel is placed into the closure panel implantation catheter along with the guide ring, the support rod and one end of the pull wire.
  • the flexible closed plate in the mitral flexible closure plate blocking body of the invention is made of a flexible material with excellent ductility, and is implanted through a small incision of the left chest of the human body.
  • the apex enters the left ventricle and is placed and fixed to the regurgitation of the mitral valve at the anterior and posterior lobes.
  • the mitral valve opens and the blood passes through the two channels between the anterior and posterior leaflets and the closure plate.
  • the regurgitation channel of the valve effectively prevents mitral regurgitation.
  • the flexible closure plate has a simple structure and high reliability, and the implantation method has small trauma to the human body, and the incidence of residual reflux is very low, and the treatment of functional mitral regurgitation and the like can be performed, and the functional apex can be repaired. The success rate of regurgitation is over 90%.
  • Figure 1 is a view of the structure of the heart and the position of the mitral valve
  • FIG. 2 is an enlarged view of the tissue structure of the mitral valve of Figure 1;
  • Figure 3 is a right side view of the mitral valve of Figure 2 when closed;
  • Figure 4 is a partial enlarged view of the atrium of Figure 2 when the mitral valve is closed;
  • Figure 5 is a right side view of the mitral regurgitation of the systolic mitral regurgitation in Figure 2;
  • Figure 6 is a partial enlarged view of the atrial mitral regurgitation in the systolic mitral regurgitation of Figure 2;
  • FIG. 7 is a schematic view of a transapical mitral flexible closure plate occlusion body implanted according to the present invention.
  • Figure 8 is an enlarged view of the hook card structure of Figure 7;
  • Figure 9 is a schematic view of the hook card of Figure 8 placed in the hook card implant catheter;
  • Figure 10 is a schematic view showing the implantation state of a mitral flexible closure plate occlusion body according to the present invention.
  • a structure of a apical flexible occlusion flap occlusion body includes a hook card 6, The flexible closure panel 7, the guide wire 8, the traction wire 10, the guide ring 13, the support rod 14 and the fixed plug 12.
  • the fixation plug 12 is implanted at the apex 4 .
  • the flexible closure plate 7 is made of a flexible material with excellent ductility, and the longitudinal section has an inverted isosceles trapezoidal structure with a front and rear thickness of 5-6 mm, and the length of the upper base of the isosceles trapezoid is longer than the length of the lower base.
  • the flexible closure panels 7 are capable of being tightly crimped into an elongated cylinder along their mutually parallel upper or lower base edges.
  • the flexible closure plate 7 is placed between the anterior and posterior leaflets of the mitral valve of the heart after implantation, at the anterior and posterior leaflet junctions of the anterior leaflet 2.2 and the free edge of the posterior leaflet 2.3, and the flexible closure plate 7 is used to block the two lobes The backflow channel formed by the incomplete closure of the leaf.
  • a guide ring 13 is fixedly connected to each of the lower left portion and the lower right portion of the flexible closing plate 7.
  • the upper left portion is fixedly connected to the hook card 6 on the left side via a first guiding line 8
  • the right upper portion of the flexible closing plate 7 is fixedly connected to the hook card 6 on the right side via a second guiding line 8.
  • the left and right guide wires 8 pass through the guide ring 13 on the same side at the same time and then extend down to the apex 4 or the fixed plug 12 at the papillary muscle 2.5, that is, the guide wire of the first guide wire 8 passes through the left side.
  • the ring 13 is extended downwardly and fixedly connected to the fixing plug 12, and the second guiding wire 8 passes through the guiding ring 13 on the right side and extends downwardly and fixedly connected to the fixing plug 12.
  • the guide ring 13 serves to define the course of the guide wire 8.
  • the lower bottom edge of the flexible closure panel 7 is fixedly connected to one end of the traction wire 10, and the other end of the traction wire 10 is fixedly connected to the fixing plug 12.
  • the position of the flexible closure panel 7 is fixed by the pull wire 10.
  • the flexible closure panel 7 is placed in the optimum position via the hook card 6, the pull wire 10 and the retaining plug 12.
  • a support rod 14 is embedded in the edge of the lower edge of the flexible closure panel 7 along the length of the lower base to keep the support rod 14 parallel to the lower bottom edge of the flexible closure panel 7.
  • the support rod 14 is used to support the flexible closure panel 7 to prevent the flexible closure panel 7 from being bent and deformed when the traction wire 10 is pulled by the flexible closure panel 7.
  • the hook card 6 is made of a nickel-titanium memory alloy material, and the guiding wire 8 and the pulling wire 10 are made of ePTFE (expanded polytetrafluoroethylene) material, the support rod 14 is made of a rigid material, and the flexible closing plate 7 is selected for extension.
  • the fixation plug 12 is made of a blood-compatible material, and the fixation plug 12 can lock the guide wire 8 and the traction wire 10 and be fixed at the apex 4 or the papillary muscle 2.5 position.
  • the blood compatible material is polyurethane or pericardium material, and the flexible closure plate 7 can be made of polyurethane.
  • the hook card 6 is composed of two parts, a barb 6.1 and a connecting ring 6.2. One end is two barbs 6.1, and the other end is a connecting ring 6.2. When the hook card 6 is implanted, the barb 6.1 is partially fixed to the flap. On the ring 2.1, the guide wire 8 is threaded over the connecting ring 6.2 and fixedly connected to the flexible closure plate 7, and the flexible closure plate 7 is secured to the hook card 6 by the guide wire 8.
  • the hook card 6 is first placed into the hook card implant catheter 9, and the inner diameter of the hook card implant catheter 9 is adapted to the outer diameter of the connecting ring 6.2 of the hook card 6.
  • the barb 6.1 portion is slightly bent and placed in the front end of the hook card implantation catheter 9.
  • the method of implanting the mitral flexible closure plate occlusion body into the heart is:
  • Step 1 First, make a small incision in the left apex of the chest, straight through the apex 4, and do a purse operation at the apex 4 position, insert the apical sleeve into the left ventricle 3 from the purse, tighten the purse, fix the apex tube.
  • the apex cannula is clamped by the hemostat to prevent the blood of the heart from flowing out of the implantation position; then the two guiding wires 8 are respectively placed on the connecting ring 6.2 of the hook card 6, and the connecting ring 6.2 is respectively guided twice.
  • the two hooks 6 of the lead 8 are respectively implanted in the left and right mitral annulus 2.1 of the anterior-posterior leaflet junction 5.
  • the specific method is as follows: firstly, the first guiding wire 8 is placed on the connecting ring 6.2 of the first hook card 6, and then the first hook card 6 is placed in the hook card implanting catheter 9, which is loose and happy.
  • the first hook card 6 is pushed out from the front end of the hook card implantation catheter 9 by the push rod, and the barb 6.1 is pushed out to expand, and the barb 6.1 is inserted into the left end position of the mitral annulus 2.1 by its elasticity.
  • the hook card implant catheter 9 is then withdrawn and the apical cannula is clamped by a hemostat.
  • the second guiding wire 8 is placed on the connecting ring 6.2 of the second hook card 6, and the second hook card 6 is placed in the hook card implanting catheter 9, and the pillow is inserted.
  • the hemostat of the tube is inserted into the catheter 9 through the apical cannula into the left ventricle 3, and the barb 6.1 of the second hook card 6 is inserted into the right end position of the mitral annulus 2.1.
  • the hook card implantation catheter 9 is withdrawn.
  • both ends of each of the guide wires 8 passing through the hook card 6 are guided to the outside through the apical catheter, and the apex catheter is clamped with a hemostat to prevent bleeding of the heart.
  • Step 2 Externally, the left lower portion of the flexible closure panel 7 is fixed to a left guide ring 13 and the lower right portion is fixedly coupled to a right guide ring 13.
  • the guide ring 13 is formed as a single piece together with the flexible closure panel 7.
  • One ends of the outer ends of the two guiding wires 8 which are led to the outside are respectively fixedly connected to the upper side of the flexible closing plate 7 and the other ends respectively pass through the guiding rings 13 on the same side.
  • first guiding wire 8 and the left upper part of the flexible closing plate 7 are fixedly connected, and the other end of the first guiding wire 8 passes through the left guiding ring 13 fixed on the flexible closing plate 7, second One end of the root guide wire 8 is fixedly coupled to the upper right portion of the flexible closure plate 7, and the other end of the second guide wire 8 passes through the right guide ring 13 fixed to the flexible closure plate 7.
  • the lower bottom edge of the flexible closure panel 7 is fixedly attached to one end of the pull wire 10 while the support bar 14 is fixedly embedded in the lower bottom edge of the flexible closure panel 7.
  • the guide ring 13, the support rod 14, and one end of the pull wire 10 are formed together with the flexible closure panel 7 as a single piece.
  • the flexible closure plate 7 is tightly curled into an elongated cylinder along its mutually parallel upper or lower bottom edges.
  • the flexible closure plate 7 together with the guide ring 13, the support rod 14 and one end of the traction wire 10 are placed together in the closure plate implantation catheter 11, the hemostasis of the cannula is loosened, and the closure plate is implanted into the catheter 11 from the left side of the chest.
  • a small incision is implanted through the apical cannula into the interior of the left ventricle 3.
  • the guide wire 8 passing through the guide ring 13 is guided from the apex 4 to the outside of the body via the closure plate implantation catheter 11, and the other end of the traction wire 10 is also extended outside the body via the closure plate implantation catheter 11.
  • Step 3 Pushing out the flexible closure plate 7 from the closure plate implantation catheter 11 and deploying it inside the left ventricle 3, adjusting the outer ends of the two guide wires 8 passing through the guide ring 13, and tightening the guide wire 8 so that The upper left and right upper portions of the flexible closure panel 7 are respectively located at the hook card 6 on the same side, and the flexible closure panel 7 is fixed at the front and rear leaflet joints 5.
  • the pull wire 10 is adjusted such that the lower bottom edge of the flexible closure panel 7 is tensioned by the other end of the pull wire 10.
  • Step 4 Exit the closed plate implant catheter 11, clamp the apical cannula, loosen the purse, remove the apical cannula, and tighten the purse to prevent bleeding.
  • the guide wire 8 and the outer end of the traction wire 10 are passed through the fixing plug 12, the fixing plug 12 is pushed to the apex 4 position, the purse is released, and the fixing plug 12 is placed to the apex 4, and the purse is tightened.
  • the pulling wire 10 and the guiding wire 8 After adjusting the pulling force of the pulling wire 10 and the guiding wire 8 to the optimum, the pulling wire 10 and the guiding wire 8 are locked by the fixing plug 12, and the excess pulling wire 10 and the guiding wire 8 outside the fixing plug 12 are cut off.
  • the fixing plug 12 has a small end and protrudes into the apex 4, and the other end has a large area, close to the surface of the apex 4, and has a hole in the middle of the fixing plug 12.
  • the pulling wire 10 is taken out from the hole and locked by the fixing plug 12, so that the traction can be The force of the wire 10 is evenly distributed on the surface of the apex 4.
  • Step 5 The small incision on the left side of the chest is sutured, and the implantation process of the mitral flexible closure plate obstruction is completed.
  • the mitral valve 2 When the heart is dilated, the mitral valve 2 is opened, and blood flows from the left atrium 1 into the left ventricle 3 through the two channels between the anterior leaflet 2.2, the posterior leaflet 2.3, and the flexible closure plate 7; when the heart contracts, the anterior leaflet 2.2 and the posterior leaflet 2.3 is closed, the edge of the leaflet is pressed against the flexible closure plate 7, the flexible closure plate 7 is slightly deformed, the edge of the leaflet and the slightly deformed flexible closure plate 7 are tightly joined together, blocking the opposite of the mitral valve 2 The flow channel effectively prevents backflow of the mitral valve 2.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Prostheses (AREA)

Abstract

一种人体心脏修复技术领域中经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法，将柔性闭合板（7）通过人体左侧胸部小切口植入，经心尖（4）进入左心室（3），放置并固定到二尖瓣（2）前后瓣叶闭合处（5）的反流孔位置，当心脏舒张时，二尖瓣（2）打开，血液通过前、后瓣叶（2.2、2.3）和闭合板（7）之间的两条通道从左心房（1）流入左心室（3）；当心脏收缩时，前、后瓣叶（2.2、2.3）关闭，瓣叶边缘挤压闭合板（7），使其轻微变形，瓣叶边缘和轻微变形的闭合板（7）紧密结合在一起，阻塞了二尖瓣（2）的反流通道，有效地防止了二尖瓣（2）的反流；柔性闭合板阻塞体的结构简单，可靠性强，其植入方法对人体的创伤小，残余反流发生率很低，能够进行功能性二尖瓣关闭不全等疾病的治疗，修复功能型二尖瓣反流成功率达90％以上。

Description

一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法 技术领域
本发明涉及人体心脏修复技术和医疗器械领域，尤其是一种能修复心脏二尖瓣反流的器械。
背景技术
人体心脏和瓣膜如图1所示，左心室3位于心尖4左上方，二尖瓣2位于左心房1和左心室3之间，二尖瓣2控制血液从左心房1单向流入左心室3。功能失调的二尖瓣2会导致二尖瓣2的两瓣叶关闭不全，使血液在心脏收缩期从左心室3反流回左心房1。二尖瓣反流将引起肺充血和左心室3肥大，最终导致病人的心衰和死亡。
二尖瓣2的结构如图2所示，二尖瓣2是一个复杂的承受血压的单向阀结构，由二尖瓣环2.1、前瓣叶2.2、后瓣叶2.3、腱索2.4、乳头肌2.5和左心室壁上的心肌组成。乳头肌2.5附着于左心室壁上，前瓣叶2.2、后瓣叶2.3附着在二尖瓣环2.1上。二尖瓣环2.1是一个连接前瓣叶2.2、后瓣叶2.3和左心室壁的内部组织结构。根据二尖瓣环2.1的组织结构，它被分成前内侧段的纤维层和后外侧段的肌肉层。腱索2.4起始于乳头肌2.5，附着于瓣叶上，能够防止心脏收缩时前瓣叶2.2、后瓣叶2.3塌陷进入左心房1。
功能正常的二尖瓣闭合时的状态如图3、图4所示，二尖瓣关闭后前瓣叶2.2、后瓣叶2.3之间没有间隙，前后瓣叶结合处5之间完全闭合，不会产生反流现象。当二尖瓣2闭合时的状态如图5、图6所示时，二尖瓣2的前后瓣叶结合处5之间有间隙出现，前后瓣叶结合处5间的间隙使血液在心脏收缩时从左心室3回流到左心房1(如图5中的箭头所示的反流方向)，这种回流称为二尖瓣反流，二尖瓣反流会降低心脏效率并导致心衰。
目前，对于二尖瓣反流的治疗方法，主要有瓣环整形术、机械二尖瓣或生物二尖瓣的移植等等，这些大多需要开胸、开心，对人体创伤大，可靠性不高，导致治疗后5年内50％的二尖瓣反流重新复发。现有的比较先进的微创治疗方法是通过二尖瓣钳夹，将前后瓣叶边缘的中点夹在一起，形成两个独立的血流通道，减少血液的反流，但是这种方法有残余反流发生。
发明内容
本发明的目的是解决现有二尖瓣反流治疗方法存在的问题，提供一种修复二尖瓣反流的经心尖植入的二尖瓣柔性闭合板阻塞体，阻塞二尖瓣的反流通道，有效防止二尖 瓣的反流；本发明同时还提供该二尖瓣柔性闭合板阻塞体的植入方法，经微创手术植入到二尖瓣前后瓣叶闭合处的反流孔位置，不需要开胸、开心，对人体创伤小，无残余反流发生，可靠性高。
为了达到以上目的，本发明一种经心尖植入的二尖瓣柔性闭合板阻塞体采用的技术方案是：所述二尖瓣柔性闭合板阻塞体包括柔性闭合板、导引线、导向环和固定塞，所述固定塞固定植入在心脏的心尖处，所述柔性闭合板位于心脏的前后瓣叶结合处，在前后瓣叶结合处的左、右侧的二尖瓣环中各固定植入有一个钩卡，左、右两根导引线分别穿过同侧的钩卡且固定连接柔性闭合板的同侧上部，柔性闭合板的左下部和右下部各固定连接一个导向环，左、右两根导引线分别穿过同侧的导向环并固定连接所述固定塞。
进一步地，所述柔性闭合板的纵截面为倒等腰梯形结构，柔性闭合板能够沿上底边或下底边卷曲成细长的圆柱体。
进一步地，柔性闭合板下底边的边缘内沿下底边的长度方向嵌入有一条支撑杆，柔性闭合板的下底边固定连接牵引线一端，牵引线另一端固定连接固定塞。
更进一步地，所述牵引线有多根，多根牵引线一端沿柔性闭合板下底边的长度方向均匀连接柔性闭合板，多根牵引线的另一端均固定连接于固定塞。
所述经心尖植入的二尖瓣柔性闭合板阻塞体的植入方法采用的技术方案是：在胸部左侧心尖位置做一个小切口直通心尖，在心尖位置做一个荷包手术，将心尖套管从荷包中插入左心室，收紧荷包固定心尖套管，还包含以下步骤：
A、将导引线穿在钩卡上，钩卡放置在钩卡植入导管中，钩卡植入导管经心尖套管进入左心室到达前后瓣叶结合处，通过推杆将钩卡从钩卡植入导管中推出，使钩卡插入在二尖瓣环中；先后两次分别将两个钩卡分别植入在前后瓣叶结合处的左、右侧的二尖瓣环中；在两个钩卡植入后退出钩卡植入导管，穿过钩卡的两根导引线的两端都通过心尖导管引到体外；
B、在体外先将柔性闭合板和导向环组成一个整件，将体外的两根导引线一端各自分别和柔性闭合板同侧上部固定连接、另一端各自分别穿过同侧的导向环；再将柔性闭合板卷曲成圆柱体，将圆柱体的整件放入闭合板植入导管中，闭合板植入导管经心尖套管进入到左心室内部，推出柔性闭合板使其展开，穿过导向环的导引线经闭合板植入导管引向体外，最后拉紧导引线使柔性闭合板的左上部和右上部分别位于同侧的钩卡位置；
C、退出闭合板植入导管，取出心尖套管，用固定塞锁紧导引线。
进一步地，步骤B中，在体外将柔性闭合板下底边固定连接牵引线一端，同时将 支撑杆固定嵌入在柔性闭合板的下底边缘内，柔性闭合板连同导向环、支撑杆和牵引线一端一起放入闭合板植入导管中。
本发明采用上述技术方案后具有的优点是：本发明所述二尖瓣柔性闭合板阻塞体中的柔性闭合板由延展性极好的柔性材料制成，通过人体左侧胸部小切口植入，经心尖进入左心室，放置并固定到二尖瓣前后瓣叶闭合处的反流孔位置，当心脏舒张时，二尖瓣打开，血液通过前、后瓣叶和闭合板之间的两条通道从左心房流入左心室；当心脏收缩时，前、后瓣叶关闭，瓣叶边缘挤压闭合板，使其轻微变形，瓣叶边缘和轻微变形的闭合板紧密结合在一起，阻塞了二尖瓣的反流通道，有效地防止了二尖瓣的反流。柔性闭合板阻塞体的结构简单，可靠性强，其植入方法对人体的创伤小，残余反流发生率很低，能够进行功能性二尖瓣关闭不全等疾病的治疗，修复功能型二尖瓣反流成功率达90％以上。
附图说明
下面结合附图以及具体实施方式对本发明作进一步的说明，但本发明的保护范围并不限于此。
图1为心脏的结构和二尖瓣位置图；
图2为图1中二尖瓣的组织结构放大图；
图3为图2中二尖瓣关闭时的右侧视图；
图4为图2中二尖瓣关闭时的心房局部放大图；
图5为图2中心脏收缩二尖瓣关闭不全时二尖瓣反流的右侧视图；
图6为图2中心脏收缩二尖瓣关闭不全时的二尖瓣反流的心房局部放大图；
图7为本发明所述一种经心尖植入的二尖瓣柔性闭合板阻塞体植入后的示意图；
图8为图7中钩卡结构放大图；
图9为图8中的钩卡放置在钩卡植入导管中的示意图；
图10为本发明一种经心尖植入的二尖瓣柔性闭合板阻塞体的植入状态示意图。
图中：1-左心房，2-二尖瓣，2.1-二尖瓣环，2.2-前瓣叶，2.3-后瓣叶，2.4-腱索，2.5-乳头肌，3-左心室，4-心尖，5-前后瓣叶结合处，6-钩卡，6.1-倒钩，6.2-连接环，7-柔性闭合板，8-导引线，9-钩卡植入导管，10-牵引线，11-闭合板植入导管，12-固定塞，13-导向环，14-支撑杆。
具体实施方式
参见图7，本发明一种经心尖植入的二尖瓣柔性闭合板阻塞体的结构包括钩卡6、 柔性闭合板7、导引线8、牵引线10、导向环13、支撑杆14和固定塞12。固定塞12植入在心尖4处。有2个钩卡6，分别植入在前后瓣叶结合处5的二尖瓣环2.1上的左侧和右侧位置。柔性闭合板7选用延展性极好的柔性材料制成，纵截面的形状为倒立的等腰梯形结构，前后厚度为5-6mm，等腰梯形的上底边长的长度大于下底边长，柔性闭合板7能够沿自身的相互平行的上底边或下底边紧密卷曲成细长的圆柱体。柔性闭合板7植入后放置在心脏的二尖瓣的前后瓣叶之间，在前瓣叶2.2和后瓣叶2.3游离边缘的前后瓣叶结合处5，柔性闭合板7用于阻塞两瓣叶关闭不全形成的反流通道。柔性闭合板7的左下部和右下部各固定连接一个导向环13。有左、右两根导引线8，左、右两根导引线8分别穿过同侧的钩卡6，导引线8固定连接柔性闭合板7的同侧上部，即柔性闭合板7的左上部经第一根导引线8固定连接左侧的钩卡6，柔性闭合板7的右上部经第二根导引线8固定连接右侧的钩卡6。左、右两根导引线8同时穿过同侧的导向环13后向下延伸到心尖4或者乳头肌2.5处的固定塞12处，即第一根导引线8穿过左侧的导向环13后向下延伸固定连接于固定塞12，第二根导引线8穿过右侧的导向环13后向下延伸固定连接于固定塞12。导向环13用于限定导引线8的走向。
柔性闭合板7的下底边固定连接牵引线10一端，牵引线10另一端固定连接固定塞12。本发明中的牵引线10有多根，多根牵引线10一端沿柔性闭合板7下底边的长度方向均匀连接柔性闭合板7，多根牵引线10的另一端均固定连接于固定塞12，通过牵引线10固定柔性闭合板7的位置。这样，使柔性闭合板7经钩卡6、牵引线10和固定塞12放置在最佳位置。
在柔性闭合板7下底边的边缘内、沿下底边的长度方向嵌入一条支撑杆14，使支撑杆14与柔性闭合板7的下底边保持平行。支撑杆14用于支撑柔性闭合板7，防止牵引线10牵拉柔性闭合板7时柔性闭合板7发生弯曲变形。
钩卡6由镍钛记忆合金材料制成，导引线8和牵引线10均为ePTFE(膨体聚四氟乙烯)材料制成，支撑杆14为刚性材料制成，柔性闭合板7选用延展性极好的血液相容性的柔性材料制成，固定塞12为血液相容性材料制成，固定塞12能够锁定导引线8和牵引线10并固定在心尖4或乳头肌2.5位置。血液相容性的材料为聚氨酯或心包膜材料，柔性闭合板7可选用聚氨酯制作。
参见图8，钩卡6由倒钩6.1和连接环6.2两部分组成，一端是两个倒钩6.1，另一端是一个连接环6.2，钩卡6植入时以倒钩6.1部分固定卡在瓣环2.1上，导引线8穿在连接环6.2上并固定连接柔性闭合板7，通过导引线8使柔性闭合板7与钩卡6固定。
参见图9，钩卡6植入心脏前，要先将钩卡6置入钩卡植入导管9中，钩卡植入导管9的内径与钩卡6的连接环6.2的外径相适应。钩卡6置入时，将倒钩6.1部分略作弯曲变形后置入钩卡植入导管9的前端。
参见图1-10，将所述二尖瓣柔性闭合板阻塞体植入心脏内的方法是：
步骤1：首先，在胸部左侧心尖位置做一个小的切口，直通心尖4，并在心尖4位置做一个荷包手术，将心尖套管从荷包中插入左心室3，收紧荷包，固定心尖套管。心尖套管通过止血钳夹住，防止心脏血液从植入位置流出；然后将两根导引线8各穿在钩卡6的连接环6.2上，先后两次分别将连接环6.2上穿有导引线8的两个钩卡6分别植入在前后瓣叶结合处5的左、右侧的二尖瓣环2.1中。其具体方法为：先将第一根导引线8穿在第一个钩卡6的连接环6.2上，再将该第一个钩卡6放置在钩卡植入导管9中，松开心尖套管的止血钳，将钩卡植入导管9由左侧胸部小切口经心尖套管进入左心室3，到达二尖瓣的前瓣叶2.2和后瓣叶2.3间隙两端的二尖瓣环2.1位置，通过推杆将该第一个钩卡6从钩卡植入导管9的前端推出，倒钩6.1被推出展开后通过其弹性使倒钩6.1插入在二尖瓣环2.1的左端位置中。再退出钩卡植入导管9，心尖套管通过止血钳夹住。用同样的方法，将第二根导引线8穿在第二个钩卡6的连接环6.2上，再将该第二个钩卡6放置在钩卡植入导管9中，松开心尖套管的止血钳，将钩卡植入导管9经心尖套管进入左心室3，将第二个钩卡6的倒钩6.1插入在二尖瓣环2.1的右端位置中。这样，两个钩卡6植入后，退出钩卡植入导管9。此时，穿过钩卡6的每根导引线8的两端都通过心尖导管引到体外，用止血钳夹紧心尖导管，防止心脏出血。
步骤2：在体外，将柔性闭合板7的左下部固定一个左侧导向环13、右下部固定连接一个右侧导向环13。或者在制造柔性闭合板7时，就将导向环13与柔性闭合板7一起做成一个整件。引到体外的两根导引线8体外端的一端各自分别和柔性闭合板7同侧上部固定连接、另一端各自分别穿过同侧的导向环13。即：将第一根导引线8一端和柔性闭合板7的左上部固定连接，第一根导引线8另一端穿过固定在柔性闭合板7上的左侧的导向环13，第二根导引线8一端和柔性闭合板7的右上部固定连接，第二根导引线8另一端穿过固定在柔性闭合板7上的右侧的导向环13。
将柔性闭合板7的下底边固定连接牵引线10一端，同时将支撑杆14固定嵌入在柔性闭合板7的下底边缘内。或者在制造柔性闭合板7时，就将导向环13、支撑杆14、牵引线10一端与柔性闭合板7一起做成一个整件。
将柔性闭合板7沿自身的相互平行的上底边或下底边紧密卷曲成细长的圆柱体， 柔性闭合板7连同导向环13、支撑杆14以及牵引线10一端均一起放入闭合板植入导管11中，松开心尖套管的止血钳，将闭合板植入导管11由胸部左侧的小切口植入，经心尖套管进入到左心室3内部。此时，穿过导向环13的导引线8从心尖4经闭合板植入导管11引向体外，牵引线10的另一端也经闭合板植入导管11伸出在体外。
步骤3：将柔性闭合板7从闭合板植入导管11中推出，在左心室3内部展开，调节两根穿过导向环13的导引线8的体外端，拉紧导引线8，使柔性闭合板7的左上部和右上部分别位于同侧的钩卡6位置，将柔性闭合板7在前后瓣叶结合处5固定好。调节牵引线10，使柔性闭合板7下底边通过牵引线10另一端拉紧。
步骤4：退出闭合板植入导管11，钳紧心尖套管，松开荷包，将心尖套管取出，再收紧荷包，防止心脏出血。将导引线8和牵引线10的体外端穿过固定塞12，将固定塞12推向心尖4位置，松开荷包，将固定塞12放置到心尖4后，收紧荷包固定。调整牵引线10和导引线8的拉力达到最佳后，通过固定塞12锁紧牵引线10和导引线8，将固定塞12外面多余的牵引线10和导引线8剪除。固定塞12一端细小，伸入心尖4，另一端部面积较大，贴近心尖4表面，固定塞12中间有孔，牵引线10从孔中引出，用固定塞12锁紧固定，这样可以将牵引线10的受力均匀分布在心尖4表面。
步骤5：将胸部左侧小切口缝合，二尖瓣柔性闭合板阻塞体的植入过程结束。
当心脏舒张时，二尖瓣2打开，血液通过前瓣叶2.2、后瓣叶2.3和柔性闭合板7之间的两条通道从左心房1流入左心室3；当心脏收缩时，前瓣叶2.2和后瓣叶2.3关闭，瓣叶边缘挤压柔性闭合板7，使柔性闭合板7轻微变形，瓣叶边缘和轻微变形的柔性闭合板7紧密结合在一起，阻塞了二尖瓣2的反流通道，有效地防止了二尖瓣2的反流。

Claims (10)

  1. 一种经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：包括柔性闭合板(7)、导引线(8)、导向环(13)和固定塞(12)，所述固定塞(12)固定植入在心脏的心尖(4)处，所述柔性闭合板(7)位于心脏的前后瓣叶结合处，在前后瓣叶结合处的左、右侧的二尖瓣环(2.1)中各固定植入有一个钩卡(6)，左、右两根导引线(8)分别穿过同侧的钩卡(6)且固定连接柔性闭合板(7)的同侧上部，柔性闭合板(7)的左下部和右下部各固定连接一个导向环(13)，左、右两根导引线(8)分别穿过同侧的导向环(13)并固定连接所述固定塞(12)。
  2. 根据权利要求1所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：柔性闭合板(7)下底边的边缘内沿下底边的长度方向嵌入有一条支撑杆(14)，柔性闭合板(7)的下底边固定连接牵引线(10)一端，牵引线(10)另一端固定连接固定塞(12)。
  3. 根据权利要求2所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：所述牵引线(10)有多根，多根牵引线(10)一端沿柔性闭合板(7)下底边的长度方向均匀连接柔性闭合板(7)，多根牵引线(10)的另一端均固定连接于固定塞(12)。
  4. 根据权利要求1所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：所述柔性闭合板(7)的纵截面为倒等腰梯形结构，柔性闭合板(7)能够沿上底边或下底边卷曲成细长的圆柱体。
  5. 根据权利要求1所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：钩卡(6)由镍钛记忆合金材料制成，固定塞(12)由血液相容性材料制成，柔性闭合板(7)由血液相容性的柔性材料制成，导引线(8)由膨体聚四氟乙烯材料制成。
  6. 根据权利要求2所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：牵引线(10)由膨体聚四氟乙烯材料制成，支撑杆(14)由刚性材料制成。
  7. 根据权利要求1所述经心尖植入的二尖瓣柔性闭合板阻塞体，其特征是：钩卡(6)由倒钩(6.1)和连接环(6.2)两部分组成，导引线穿在连接环(6.2)上。
  8. 一种如权利要求1所述经心尖植入的二尖瓣柔性闭合板阻塞体的植入方法，在胸部左侧心尖位置做一个小切口直通心尖(4)，在心尖(4)位置做一个荷包手术，将心尖套管从荷包中插入左心室(3)，收紧荷包固定心尖套管，其特征是还包含以下步骤：
    A、将导引线(8)穿在钩卡(6)上，钩卡(6)放置在钩卡植入导管(9)中，钩卡 植入导管(9)经心尖套管进入左心室(3)到达前后瓣叶结合处，通过推杆将钩卡(6)从钩卡植入导管(9)中推出，使钩卡(6)插入在二尖瓣环(2.1)中；先后两次分别将两个钩卡(6)分别植入在前后瓣叶结合处的左、右侧的二尖瓣环(2.1)中；在两个钩卡(6)植入后退出钩卡植入导管(9)，穿过钩卡(6)的两根导引线(8)的两端都通过心尖导管引到体外；
    B、在体外先将柔性闭合板(7)和导向环(13)组成一个整件，将体外的两根导引线(8)一端各自分别和柔性闭合板(7)同侧上部固定连接、另一端各自分别穿过同侧的导向环(13)；再将柔性闭合板(7)卷曲成圆柱体，将圆柱体的整件放入闭合板植入导管(11)中，闭合板植入导管(11)经心尖套管进入到左心室(3)内部，推出柔性闭合板(7)使其展开，穿过导向环(13)的导引线(8)经闭合板植入导管(11)引向体外，最后拉紧导引线(8)使柔性闭合板(7)的左上部和右上部分别位于同侧的钩卡(6)位置；
    C、退出闭合板植入导管(11)，取出心尖套管，用固定塞(12)锁紧导引线(8)。
  9. 根据权利要求8所述经心尖植入的二尖瓣柔性闭合板阻塞体的植入方法，其特征是：步骤B中，在体外将柔性闭合板(7)下底边固定连接牵引线(10)一端，同时将支撑杆(14)固定嵌入在柔性闭合板(7)的下底边缘内，柔性闭合板(7)连同导向环(13)、支撑杆(14)和牵引线(10)一端一起放入闭合板植入导管(11)中。
  10. 根据权利要求8所述经心尖植入的二尖瓣柔性闭合板阻塞体的植入方法，其特征是：步骤A中，导引线(8)一端穿在钩卡(6)的连接环(6.2)部分，钩卡(6)的倒钩(6.1)部分插入在心脏的二尖瓣环(2.1)中。
PCT/CN2016/108785 2016-04-14 2016-12-07 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法 WO2017177701A1 (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US16/086,508 US11007060B2 (en) 2016-04-14 2016-12-07 Transapically-implanted mitral valve flexible coaptation plate blocking body and implantation method
EP16898513.3A EP3443937B1 (en) 2016-04-14 2016-12-07 Apical implantation mitral valve flexible closure plate blocking body and implantation method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610229742.0 2016-04-14
CN201610229742.0A CN105852916B (zh) 2016-04-14 2016-04-14 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法

Publications (1)

Publication Number Publication Date
WO2017177701A1 true WO2017177701A1 (zh) 2017-10-19

Family

ID=56638004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/108785 WO2017177701A1 (zh) 2016-04-14 2016-12-07 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法

Country Status (4)

Country Link
US (1) US11007060B2 (zh)
EP (1) EP3443937B1 (zh)
CN (1) CN105852916B (zh)
WO (1) WO2017177701A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
WO2017100927A1 (en) 2015-12-15 2017-06-22 Neovasc Tiara Inc. Transseptal delivery system
CN105852916B (zh) * 2016-04-14 2018-02-06 上海甲悦医疗器械有限公司 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法
CN115137529A (zh) 2016-12-21 2022-10-04 特里弗洛心血管公司 心脏瓣膜支撑装置及用于制造和使用该装置的方法
US10856984B2 (en) 2017-08-25 2020-12-08 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
CN109009569B (zh) * 2018-09-07 2020-08-04 谭雄进 一种人工二尖瓣介入置换装置及其介入方法
US11737872B2 (en) 2018-11-08 2023-08-29 Neovasc Tiara Inc. Ventricular deployment of a transcatheter mitral valve prosthesis
US11998447B2 (en) 2019-03-08 2024-06-04 Neovasc Tiara Inc. Retrievable prosthesis delivery system
EP3952792A4 (en) 2019-04-10 2023-01-04 Neovasc Tiara Inc. HEART VALVE PROSTHESIS WITH NATURAL BLOOD FLOW
CA3140925A1 (en) 2019-05-20 2020-11-26 Neovasc Tiara Inc. Introducer with hemostasis mechanism
US10842628B1 (en) 2019-05-22 2020-11-24 TriFlo Cardiovascular Inc. Heart valve support device
US11311376B2 (en) 2019-06-20 2022-04-26 Neovase Tiara Inc. Low profile prosthetic mitral valve
CN111358597B (zh) * 2020-03-19 2022-03-29 中国医学科学院阜外医院 多功能二尖瓣成形装置
CN112168427A (zh) * 2020-11-02 2021-01-05 上海竑宇医疗科技有限公司 一种心尖植入尖瓣夹合装置及心尖植入尖瓣夹合方法
CN114767180B (zh) * 2022-04-11 2023-05-12 四川大学华西医院 一种房间隔缺损封堵器

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692164A (en) * 1986-03-06 1987-09-08 Moskovskoe Vysshee Tekhnicheskoe Uchilische, Imeni N.E. Baumana Bioprosthetic heart valve, methods and device for preparation thereof
CN103491902A (zh) * 2011-04-01 2014-01-01 爱德华兹生命科学公司 可压缩心脏瓣环定型模板
CN104042359A (zh) * 2014-06-30 2014-09-17 江苏大学 一种修复二尖瓣反流的自适应定位的二尖瓣闭合板阻塞体
CN104055605A (zh) * 2014-07-07 2014-09-24 宁波健世生物科技有限公司 一种用于阻止瓣膜反流的假体
CN105455924A (zh) * 2014-09-26 2016-04-06 Nvt股份公司 用于治疗心脏瓣膜反流的可植入装置
CN105852916A (zh) * 2016-04-14 2016-08-17 江苏大学 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1205905A1 (ru) * 1983-05-19 1986-01-23 Всесоюзный научно-исследовательский и проектно-конструкторский институт промышленных гидроприводов и гидроавтоматики Протез дл митрального клапана сердца
FR2708847B1 (fr) * 1993-08-13 1995-11-03 Couetil Jean Paul Valve cardiaque implantable.
US6869444B2 (en) * 2000-05-22 2005-03-22 Shlomo Gabbay Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve
US20050038509A1 (en) * 2003-08-14 2005-02-17 Ashe Kassem Ali Valve prosthesis including a prosthetic leaflet
EP2358297B1 (en) * 2008-11-21 2019-09-11 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis
US20100262233A1 (en) * 2009-04-12 2010-10-14 Texas Tech University System Mitral Valve Coaptation Plate For Mitral Valve Regurgitation
EP2424468A1 (en) * 2009-04-29 2012-03-07 Carlo Antona A prosthesis for repairing heart valves
US8845717B2 (en) 2011-01-28 2014-09-30 Middle Park Medical, Inc. Coaptation enhancement implant, system, and method
US8888843B2 (en) 2011-01-28 2014-11-18 Middle Peak Medical, Inc. Device, system, and method for transcatheter treatment of valve regurgitation
US20140067048A1 (en) 2012-09-06 2014-03-06 Edwards Lifesciences Corporation Heart Valve Sealing Devices
US9248018B2 (en) * 2013-09-27 2016-02-02 Surendra K. Chawla Valve repair device
US10531956B2 (en) * 2015-09-03 2020-01-14 Vesalous Cardiovascular Inc. Apparatus for repairing heart valves and method of use thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692164A (en) * 1986-03-06 1987-09-08 Moskovskoe Vysshee Tekhnicheskoe Uchilische, Imeni N.E. Baumana Bioprosthetic heart valve, methods and device for preparation thereof
CN103491902A (zh) * 2011-04-01 2014-01-01 爱德华兹生命科学公司 可压缩心脏瓣环定型模板
CN104042359A (zh) * 2014-06-30 2014-09-17 江苏大学 一种修复二尖瓣反流的自适应定位的二尖瓣闭合板阻塞体
CN104055605A (zh) * 2014-07-07 2014-09-24 宁波健世生物科技有限公司 一种用于阻止瓣膜反流的假体
CN105455924A (zh) * 2014-09-26 2016-04-06 Nvt股份公司 用于治疗心脏瓣膜反流的可植入装置
CN105852916A (zh) * 2016-04-14 2016-08-17 江苏大学 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3443937A4 *

Also Published As

Publication number Publication date
CN105852916A (zh) 2016-08-17
US20190117386A1 (en) 2019-04-25
EP3443937B1 (en) 2023-03-08
CN105852916B (zh) 2018-02-06
EP3443937A4 (en) 2019-12-18
EP3443937A1 (en) 2019-02-20
US11007060B2 (en) 2021-05-18

Similar Documents

Publication Publication Date Title
WO2017177701A1 (zh) 一种经心尖植入的二尖瓣柔性闭合板阻塞体及植入方法
WO2017177700A1 (zh) 一种经心尖植入的二尖瓣气囊闭合板阻塞体及植入方法
CN111970996B (zh) 心脏瓣膜密封装置及其递送装置
EP3697324B1 (en) System for plicating a heart valve
CN111200995B (zh) 用于心脏瓣膜的假体间隔件装置
JP7204665B2 (ja) 心臓弁封止デバイスおよびその送達デバイス
JP5139420B2 (ja) 心臓弁の修復
JP2019536511A (ja) 弁膜留め具
US10292711B2 (en) Mitral valve treatment device having left atrial appendage closure
US7037334B1 (en) Method and apparatus for catheter-based annuloplasty using local plications
US6718985B2 (en) Method and apparatus for catheter-based annuloplasty using local plications
WO2022151622A1 (zh) 瓣膜假体和瓣膜假体系统
US20160324637A1 (en) Method and apparatus for catheter-based annuloplasty using local plications
JP2024503697A (ja) 心臓弁密封デバイスおよびそのための送達デバイス
CN114727864A (zh) 具有接合结构和多个小叶捕获夹子的瓣膜修复装置
US20210378818A1 (en) Devices and methods for repair of valvular insufficiency
US20150057682A1 (en) Clip delivery system for heart valve repair and method of use
CN110603007A (zh) 用于经导管二尖瓣和三尖瓣修复的装置和方法
WO2002085252A1 (en) Method and apparatus for catheter-based annuloplasty using local plications
CN111479531B (zh) 用于瓣膜修复的连接的锚固件输送系统和方法
WO2023275791A1 (en) Transcatheter annuloplasty locking systems, devices and methods
TW202224648A (zh) 用於心臟瓣膜瓣葉修復的系統及方法
CN109803612A (zh) 用于导管输送植入物的可调节且可逆的锁定机构
KR20210030926A (ko) 이식 가능한 심장 판막 개선 디바이스, 시스템 및 절차

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2016898513

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016898513

Country of ref document: EP

Effective date: 20181114

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16898513

Country of ref document: EP

Kind code of ref document: A1